Your browser doesn't support javascript.
loading
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Sehouli, J; Chekerov, R; Reinthaller, A; Richter, R; Gonzalez-Martin, A; Harter, P; Woopen, H; Petru, E; Hanker, L C; Keil, E; Wimberger, P; Klare, P; Kurzeder, C; Hilpert, F; Belau, A K; Zeimet, A; Bover-Barcelo, I; Canzler, U; Mahner, S; Meier, W.
Affiliation
  • Sehouli J; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité University Hospital of Berlin, Berlin, Germany jalid.sehouli@charite.de.
  • Chekerov R; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité University Hospital of Berlin, Berlin, Germany.
  • Reinthaller A; Department of Gynecology and Gynecologic Oncology, Medical University of Vienna, Vienna, Austria.
  • Richter R; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité University Hospital of Berlin, Berlin, Germany.
  • Gonzalez-Martin A; Department of Medical Oncology, MD Anderson Cancer Center Spain, Madrid, Spain.
  • Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
  • Woopen H; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité University Hospital of Berlin, Berlin, Germany.
  • Petru E; Department of Obstetrics and Gynecology, Division of Gynecology, Medical University of Graz, Austria.
  • Hanker LC; Department of Obstetrics and Gynaecology, Johann Wolfgang Goethe-University Frankfurt am Main.
  • Keil E; Department of Gynecology, Park Clinic Weißensee, Berlin.
  • Wimberger P; Department of Gynecology and Obstetrics, Carl-Gustav Carus University, Dresden.
  • Klare P; Gynecological Practice for Gynecologic Oncology and Women's Health, Berlin.
  • Kurzeder C; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
  • Hilpert F; Department of Gynaecology and Obstetrics, University Hospital, Campus Kiel, Kiel.
  • Belau AK; Department of Gynaecology and Obstetrics, University Hospital Greifswald, Greifswald, Germany.
  • Zeimet A; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Innsbruck Medical University, Innsbruck, Austria.
  • Bover-Barcelo I; Servicio de Oncología del Hospital Son Llazer de Palma de Mallorca, Mallorca, Spain.
  • Canzler U; Department of Gynecology and Obstetrics, Carl-Gustav Carus University, Dresden.
  • Mahner S; Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg.
  • Meier W; Department of Gynecology and Obstetrics, Evangelisches Krankenhaus, Duesseldorf, Germany.
Ann Oncol ; 27(12): 2236-2241, 2016 12.
Article de En | MEDLINE | ID: mdl-27789470

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Protocoles de polychimiothérapie antinéoplasique / Carboplatine / Topotécane / Récidive tumorale locale Type d'étude: Clinical_trials Aspects: Patient_preference Limites: Adult / Aged / Aged80 / Female / Humans / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2016 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Protocoles de polychimiothérapie antinéoplasique / Carboplatine / Topotécane / Récidive tumorale locale Type d'étude: Clinical_trials Aspects: Patient_preference Limites: Adult / Aged / Aged80 / Female / Humans / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2016 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni